Heroin Addiction

What is heroin?

Heroin is a semi-synthetic opioid derived from morphine, which itself comes from the opium poppy. It was first synthesized in 1898 and marketed briefly as a 'non-addictive' alternative to morphine before its dependence potential became clear. It has been a Schedule I controlled substance in the United States since 1970, meaning it has no accepted medical use and a high potential for abuse.

Heroin is sold in several forms: white or brown powder (typically snorted or dissolved and injected), and black tar heroin (a dark, sticky substance common in western states, typically injected). In the current drug market, the product sold as heroin frequently contains little or no heroin at all, having been replaced or cut with illicit fentanyl or fentanyl analogs. This means someone buying what they believe is heroin may actually be using pure fentanyl, with none of the tolerance they have built to heroin providing protection.

Heroin belongs to the opioid class and acts through the same mechanism as prescription opioids and fentanyl. However, its speed of onset, particularly when injected intravenously, produces an extremely intense rush that makes it highly reinforcing for the brain's reward system. This rapid onset drives faster development of tolerance and dependence compared to slower-acting opioids.

How heroin addiction develops

Heroin binds to mu-opioid receptors in the brain, spinal cord, and peripheral nervous system. When injected intravenously, it crosses the blood-brain barrier in seconds and is converted to morphine. The result is an intense rush of warmth and euphoria followed by a prolonged state of sedated well-being. No natural experience produces this level of reward signal, and the brain records it indelibly.

With repeated use, the brain's plasticity works against the person. Opioid receptors down-regulate. The brain produces less of its own endorphins. The person becomes physically dependent, meaning their nervous system now requires heroin to function without withdrawal. This is not a choice or a character defect; it is a physiological adaptation to chronic opioid exposure.

Tolerance drives escalation. The same dose that produced powerful euphoria initially produces only normalcy within weeks to months. The person uses more, more often, to avoid feeling sick. The dopamine-driven craving becomes consuming. Life reorganizes around the drug: where to get it, how to afford it, managing withdrawal between doses.

Heroin use disorder meets the DSM-5 criteria for Opioid Use Disorder (OUD). The severe end of the spectrum, six or more diagnostic criteria, is common among people with heroin dependence because the drug's potency and pharmacokinetics produce rapid and profound neurobiological changes.

A significant portion of people with heroin use disorder began with prescription opioids. When the prescription ended or became inaccessible, heroin was cheaper and more available. This transition does not indicate moral failure; it is a predictable outcome of opioid pharmacology combined with inadequate pain management and limited early intervention.

Physical and psychological signs of heroin use and addiction

The signs of heroin use and emerging addiction are often distinctive because of the drug's specific effects on the nervous system. Some signs are visible to family and friends; others are internal experiences.

• Extreme drowsiness or 'nodding off' -- repeatedly falling asleep mid-sentence or mid-activity
• Pinpoint pupils regardless of lighting
• Slow, shallow breathing; pale or grayish skin in more serious cases
• Track marks on arms, legs, hands, or feet from injection; or bruising, abscesses
• Burned or blackened spoons, syringes, tourniquets, or other injection paraphernalia
• Runny nose, watery eyes, or nose damage in people who snort heroin
• Sudden change in social circle and loss of contact with longtime friends and family
• Dramatic financial problems: selling belongings, borrowing money with no repayment, or unexplained cash
• Withdrawal symptoms within 8 to 12 hours of last use: restlessness, muscle aches, runny nose, chills, anxiety
• Rapid mood shifts: extreme sedation when using, agitation and anxiety when not
• Declining hygiene, weight loss, and deteriorating physical health

The fentanyl contamination problem

The single most important thing to understand about heroin in New Jersey and across the country today is that the supply is contaminated. What is sold as heroin routinely contains illicit fentanyl or fentanyl analogs, often in varying concentrations that even experienced users cannot predict or control.

This contamination has fundamentally changed the risk profile of heroin use. People who have been using heroin for years and believe they know their tolerance are now regularly encountering doses of fentanyl that exceed what their tolerance can manage. A hot spot in a baggie, a batch that is substantially stronger than expected, can kill before there is time to react.

Fentanyl test strips, available at pharmacies and harm-reduction programs in New Jersey, can detect fentanyl in a drug supply. They are not a guarantee of safety but they are a meaningful harm-reduction tool. Naloxone should be in the hands of every person using opioids and every family member who may encounter an overdose.

New Jersey's Good Samaritan Law (N.J.S.A. 2C:35-30) provides legal protection from prosecution for the possession of a controlled dangerous substance when someone calls 911 to report a drug overdose in good faith. Fear of legal consequences should not prevent anyone from calling for help in an overdose emergency.

Heroin withdrawal: timeline and medical considerations

Heroin withdrawal is not typically life-threatening for otherwise healthy adults, but it is severe. The intensity drives many people back to use before withdrawal completes, and the drop in tolerance during withdrawal means returning to the previous dose after days of abstinence significantly raises the overdose risk.

Timeline for heroin/short-acting opioid withdrawal:

Hours 8 to 24: Early symptoms begin. Anxiety, restlessness, yawning, runny nose, muscle aches, light sweating, and goosebumps (hence the phrase 'cold turkey').

Hours 24 to 72: Peak symptoms. Severe muscle cramping and pain, vomiting, diarrhea, abdominal cramping, insomnia, elevated blood pressure and heart rate, chills and sweating alternating, and overwhelming cravings. This is the period most people find unbearable without medical support.

Days 4 to 7: Gradual improvement. Acute physical symptoms diminish, though fatigue, dysphoria, and insomnia persist.

Weeks to months: Post-acute withdrawal syndrome (PAWS). Anxiety, depression, anhedonia (inability to feel pleasure), sleep disturbance, and intermittent cravings. This is the biological landscape of early recovery and one of the primary reasons MAT is valuable: it supports the brain through this extended recalibration period.

Archangel coordinates with medically supervised detox partners for clients who need withdrawal management before entering our outpatient programs. We do not provide inpatient or residential detox on-site, but we guide clients through the transition from safe medical detox directly into our PHP or IOP.

Medication-assisted treatment for heroin use disorder

MAT is the evidence-based standard for heroin and all opioid use disorder. The same three FDA-approved medications apply:

Buprenorphine (Suboxone, Sublocade): The most widely used MAT option for heroin use disorder in outpatient settings. A partial opioid agonist, buprenorphine eliminates withdrawal and cravings while its ceiling effect limits overdose risk. Suboxone is taken as a daily sublingual film; Sublocade is a monthly injectable buprenorphine formulation that provides consistent blood levels and removes daily dosing as a compliance barrier. Buprenorphine prescriptions can be initiated and managed in an outpatient clinical setting, which makes it highly compatible with our IOP and PHP programs.

Methadone: Dispensed daily at federally licensed opioid treatment programs, methadone is highly effective for people with severe or long-standing heroin use disorder who have not responded adequately to buprenorphine. The daily clinic attendance provides structure and monitoring that some clients benefit from.

Naltrexone (Vivitrol): A monthly opioid antagonist injection that blocks all opioid effects. Requires seven to fourteen days of complete opioid abstinence before initiation to avoid precipitated withdrawal. A strong option for people who prefer a non-opioid medication and who have successfully completed detox.

Clinical research on MAT for heroin use disorder is robust. Buprenorphine maintenance reduces heroin use, overdose deaths, criminal activity, and HIV transmission. Long-term MAT is not a failure of recovery; it is, for many people, the most evidence-supported path to sustained recovery.

Co-occurring mental health conditions

Heroin use disorder does not develop in a vacuum. Research consistently shows high rates of co-occurring depression, anxiety, PTSD, and trauma histories among people with heroin use disorder. In many cases, the drug was initially used as self-medication for emotional pain that felt otherwise unmanageable.

Adverse childhood experiences (ACEs) are particularly prevalent in this population. Early trauma shapes the nervous system in ways that increase vulnerability to both mental health conditions and substance use disorders. Understanding this context does not excuse the addiction or remove personal responsibility for recovery, but it does shape what effective treatment looks like.

At Archangel, dual-diagnosis assessment is standard at intake. Mental health treatment is integrated into the addiction treatment plan, not treated as a separate problem to address after recovery is achieved. Trauma-informed care, CBT, and when clinically indicated, EMDR and other trauma-focused modalities are part of our clinical approach.

Heroin treatment in Monmouth County: The Archangel Centers

The Archangel Centers is a licensed outpatient addiction treatment provider at 44 Apple St STE 3, Tinton Falls, NJ, serving the Monmouth County and Jersey Shore communities. Our outpatient levels of care include PHP (Partial Hospitalization Program), IOP (Intensive Outpatient Program), and standard outpatient follow-up.

For heroin use disorder, treatment typically begins after a medically supervised detox. We coordinate with detox partners to ensure a clean handoff into structured outpatient care. Clients in our programs receive individualized treatment plans built around their specific needs: MAT integration, group and individual therapy, family support, relapse prevention skills, and ongoing accountability.

Our clinical team includes licensed counselors and therapists with training in addiction treatment, trauma-informed care, and dual-diagnosis. MAT prescribers work within our network to ensure medication management is coordinated with behavioral treatment rather than siloed.

Most major insurance plans and New Jersey Medicaid cover our levels of care. We verify benefits before admission.

What recovery from heroin addiction looks like

Recovery from heroin use disorder is a process, not a moment. The early weeks are hard: PAWS produces dysphoria and emotional flatness that can make sobriety feel worse than using. MAT helps stabilize this period significantly. Group therapy provides the experience of being understood by people who have been through the same thing.

Over months, the picture shifts. Sleep improves. Cognitive clarity returns. Relationships begin to heal. Clients who came in broken often describe a point when they realized they were genuinely looking forward to their day.

Long-term recovery from heroin use disorder is common and well-documented. It does require genuine engagement with treatment, a willingness to use medication if clinically indicated, and building a recovery-supportive life structure. That is exactly what our program is designed to support.